Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07YMP
|
|||
| Drug Name |
TAB001
|
|||
| Indication | Advanced malignancy [ICD-11: 2A00-2F9Z; ICD-10: C00-C96; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Shanghai Junshi Biosciences Shanghai, China
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.